ACTA1 and Hepatic fibrosis: Consistent with in vitro study, the in vivo study showed that PL significantly alleviated CCl4-induced hepatic fibrosis in rats, including attenuation of liver damage as well as decreased expression of myofibroblast marker, α-SMA.